Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2006; 12(13): 2075-2079
Published online Apr 7, 2006. doi: 10.3748/wjg.v12.i13.2075
Published online Apr 7, 2006. doi: 10.3748/wjg.v12.i13.2075
Table 1 Backgrounds of patients without or with history of treatment
Patients without history of HCC(n=37) | Patients with history of HCC(n=84) | P value | |
Age (yr) | 66.4 ± 9.9 | 67.0 ± 8.1 | NS |
Sex (male ∶ female) | 32∶5 | 64∶20 | NS |
Frequency of positive for anti-HCV | 72% | 81% | NS |
TNM stage (II ∶ III) | 12∶25 | 35∶49 | NS |
Tumor size (mm) | 46.4 ± 23.5 | 27.7 ± 16.1 | P < 0.01 |
Number of tumors ( ≤3 ∶ >3) | 21∶16 | 23∶61 | P < 0.01 |
Monolobular ∶ bilobular | 17∶20 | 27∶57 | NS |
Child-Pugh class (A ∶ B) | 27∶10 | 48∶36 | NS |
Alanine transferase (IU/L) | 63.8 ± 45.1 | 82.1 ± 64.3 | P = 0.07 |
AFP ( ≤100 ∶ >100 ng/mL) | 23∶14 | 53∶31 | NS |
TAE with or without anti-cancer medication | 13∶24 | 17∶67 | NS |
Average number of past treatments | - | 2.9 ± 2.2 | - |
History of hepatectomy | - | 18% | - |
Average observation period (d) | 557.6 ± 377.0 | 493.6 ± 390.6 | NS |
- Citation: Hiraoka A, Kumagi T, Hirooka M, Uehara T, Kurose K, Iuchi H, Hiasa Y, Matsuura B, Michitaka K, Kumano S, Tanaka H, Yamashita Y, Horiike N, Mochizuki T, Onji M. Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol 2006; 12(13): 2075-2079
- URL: https://www.wjgnet.com/1007-9327/full/v12/i13/2075.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i13.2075